Detection of distant metastases in head and neck cancer patients by whole body FDG-PET and whole body MRI

Detection of distant metastases in head and neck cancer patients by whole body FDG-PET and whole body MRI - Detection of distant metastases by whole body MRI

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON32960

Enrollment

Registered

2009-07-20

Start date

2009-06-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

distant metastases

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: head and neck cancer high risk factors for distant metastases candidate for extensive locoregional treatment with curative intent

Exclusion criteria

Exclusion criteria: known with distant metastases (no screening)

Design outcomes

Primary

Measure	Time frame
Primary endpoints are the proportion of clinically relevant findings (detection of distant metastases) with MRI and/or PET/CT and the diagnostic accuracy of MRI, PET/CT and combination of MRI and PET/CT.	—

Secondary

Measure	Time frame
Secondary endpoint is the interobserver agreement of MRI and PET/CT.	—

Countries

Netherlands

Outcome results